Weight-Loss Injections Are Dominating the Market: Where Will GLP-1 Pills Fit in? | News Channel 3-12

Protagonist Announces Nomination of PN-477, an Oral and Injectable GLP-1R, GIPR, and GCGR Triple Agonist Peptide Development Candidate for Obesity

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and glucagon (GCG) receptors

GOP Embraces Psychedelics; Americans Making Their Own GLP-1s; WHO on Thimerosal

(MedPage Today) -- Note that some links may require registration or subscription. The Republican party is starting to embrace psychedelics as medical treatment. (Politico) The CDC's slow delivery of funds to the nation's local public health departments...

Many People Actually Lose Muscle on a GLP-1. It's Not Too Hard to Avoid—Here's How.

This protocol will help men and women who are on a GLP-1 medication and want to lose weight, but not muscle. The five steps focus on exercise and diet.

New book by former FDA head explores the science behind GLP-1 weight loss drugs

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs containing GLP-1, a hormone that slows digestion and helps with sustained weight loss. In a new book, former FDA head Dr. David Kessler advocates for their use, but says they shouldn’t be seen as a quick and easy fix. Ali Rogin speaks with Kessler for more.

Weight-loss drugs in development aim to replace injections with pills